A photo of Gaurav Kwatra.

Gaurav Kwatra, PhD, MPH


  • Director, Laboratory for Specialized Clinical Studies, Division of Infectious Diseases
  • Associate Professor, UC Department of Pediatrics
  • Professor, Department of Medical Microbiology, Christian Medical College, Vellore, India

About

PhD: University of the Witwatersrand, Johannesburg South Africa, 2016.

PG Diploma: Pharmaceutical Regulatory Affairs, Hamdard University, New Delhi, India, 2008.

MSc: Gurukula Kangri Vishwavidyalaya, Haridwar, India, 2004.

MPH: University of the Witwatersrand, Johannesburg, South Africa, 2024.

Interests

Pregnant women; newborn and infant health; vaccine preventable infections and deaths

Interests

Immunological correlates of protection; development of new vaccine candidates; infectious diseases surveillance; sero-surveillance and immunology studies; vaccine clinical and pre-clinical studies

Research Areas

Infectious Diseases

Publications

Vaccine value profile for Klebsiella pneumoniae. Dangor, Z; Benson, N; Berkley, JA; Bielicki, J; Bijsma, MW; Broad, J; Buurman, ET; Cross, A; Duffy, EM; Holt, KE; Srikantiah, P; Tennant, SM; Hasso-Agopsowicz, M; Madhi, SA. Vaccine. 2024; 42:S125-S141.

Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study. Ji, W; Zhou, H; Li, J; Britto, CD; Liu, Z; Zhang, W; Du, J; Madhi, SA; Kwatra, G; Dangor, Z; Jin, Z; Zhao, H; Zhao, Y; Fang, Y; Li, J. Vaccine. 2024; 42:3564-3571.

Post-acute sequelae of SARS-CoV-2 infection in health care workers from South Africa. Mbotwe-Sibanda, S; Kwatra, G; Madhi, SA; Nunes, MC. Oxford Open Immunology. 2024; 5:iqae001.

Prevalence and Levels of Anti-SARS-CoV-2 Antibodies in the Eswatini Population and Subsequent Severity of the Fourth COVID-19 Epidemic Wave. Mutevedzi, PC; Lokotfwako, V; Kwatra, G; Maphalala, G; Baillie, V; Dlamini, L; Dlamini, S; Mhlanga, F; Dlamini, T; Nhlabatsi, N; Nunes, MC; Zwane, S; Madhi, SA. 2024; 4:317-333.

Combinatorial multimer staining and spectral flow cytometry facilitate quantification and characterization of polysaccharide-specific B cell immunity. Hoving, D; Marques, AH C; Huisman, W; Nosoh, BA; de Kroon, AC; van Hengel, OR J; Wu, BR; Steenbergen, RA M; van Helden, PM; Urban, BC; Dhar, N; Ferreira, DM; Kwatra, G; Hokke, CH; Jochems, SP. Communications Biology. 2023; 6:1095.

Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study. Leung, S; Collett, CF; Allen, L; Lim, S; Maniatis, P; Bolcen, SJ; Alston, B; Patel, PY; Kwatra, G; Hall, T; Thomas, S; Taylor, S; Le Doare, K; Gorringe, A. Vaccines. 2023; 11.

Serotype distribution and antimicrobial susceptibility profile of invasive group B streptococcal disease-in South Indian population. Elangovan, D; Neeravi, A; Sahni, RD; Santhanam, S; Beck, MM; Adhiya, R; kwatra, G; solaimalai, D; Veeraraghavan, B. Indian Journal of Medical Microbiology. 2023; 45:100392.

Immune responses against group B Streptococcus monovalent and pentavalent capsular polysaccharide tetanus toxoid conjugate vaccines in Balb/c mice. Dhar, N; Mohamed, E; Kirstein, F; Williams, M; Dorasamy, S; van Zyl, P; Robertson, MJ; Anderson, T; Harden, LM; Jardine, K; Veeraraghavan, B; Wilson, S; Tippoo, P; Madhi, SA; Kwatra, G. iScience. 2023; 26:107380.

Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. Madhi, SA; Anderson, AS; Absalon, J; Radley, D; Simon, R; Jongihlati, B; Strehlau, R; Van Niekerk, AM; Izu, A; Naidoo, N; Perez, JL; Scott, DA; Gruber, WC; Jansen, KU. The New England Journal of Medicine. 2023; 389:215-227.

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Kaplonek, P; Cizmeci, D; Kwatra, G; Izu, A; Lee, JS L; Bertera, HL; Fischinger, S; Mann, C; Amanat, F; Wang, W; Wuhrer, M; Lauffenburger, DA; Madhi, SA; Alter, G. Nature Immunology. 2023; 24:1161-1172.